Every publicly available treatment in New Zealand is the product of extensive research - including laboratory studies, and clinical trials.

A clinical trial is a type of research involving human participants. It can be interventional or observational.

An ovarian cancer clinical trial might evaluate a new, or existing treatment (or treatments); investigate different surgical techniques; or study behaviours - with the goal of improving outcomes for people with ovarian cancer.

Clinical trials can offer new or different treatment options for people with ovarian cancer, and help doctors make better decisions for people in the future.

There are two main avenues to learn about clinical trials - through a doctor, and the Australia New Zealand Clinical Trials Registry (ANZCTR).

The ANZCTR is an online public registry of clinical trials, held at the NHMRC Clinical Trials Centre, University of Sydney. It is a Primary Registry in the World Health Organization (WHO) Registry Network, which means that it fulfils certain criteria for content, quality and validity, accessibility, unique identification, technical capacity and administration.

Australian's with ovarian cancer can access significantly more clinical trial options than New Zealanders. Cure Our Ovarian Cancer believes access to clinical trials is important to improve ovarian cancer survival in New Zealand and are advocating for improved funding and access.